Sangamo BioSciences | SGMO - Employees Total Number

Stock Price
0.39
Daily Change
-0.01 -2.33%
Monthly
-3.50%
Yearly
-61.40%
Q1 Forecast
0.42

Sangamo BioSciences reported 405 in Employees for its fiscal year ending in December of 2023.





Employees Change Date
Alaunos Therapeutics 1 33 Dec/2023
Alnylam Pharmaceuticals 2.23K 130 Dec/2024
Alterity Therapeutics Limited AUD 12 1 Jun/2022
Amgen 28K 1.3K Dec/2024
Bayer 99.72K 1.65K Dec/2023
BioCryst Pharmaceuticals 536 5 Dec/2023
Biogen 7.6K 35 Dec/2024
BioMarin Pharmaceutical 3.04K 361 Dec/2024
Cipla 30.31K 2.55K Dec/2025
Clal Biotechnology 3 191 Dec/2023
Compugen USD 74 6 Dec/2024
CSL USD 32.06K 1.67K Dec/2025
Gilead Sciences 17.6K 400 Dec/2024
GlaxoSmithKline 69.4K 20.7K Dec/2022
Grifols EUR 23.83K 89 Dec/2024
Ionis Pharmaceuticals 1.07K 142 Dec/2024
J&J 138.1K 6.2K Dec/2024
Karyopharm Therapeutics 325 60 Dec/2023
Merck 75K 3K Dec/2024
Novartis USD 101.7K 2.62K Dec/2022
Omeros 196 17 Dec/2022
Pfizer 81K 7K Dec/2024
Roche Holding 103.61K 2.69K Dec/2022
Sangamo BioSciences 405 73 Dec/2023
Sanofi 84.59K 3.41K Dec/2024
Sarepta Therapeutics 1.37K 58 Dec/2024
Tectonic Therapeutic 45 1 Dec/2023
Ultragenyx Pharmaceutical 1.29K 18 Dec/2024
Vertex Pharmaceuticals 6.1K 700 Dec/2024